HT
NVO

HAP Trading’s Novo Nordisk NVO Stock Holding History

HAP Trading’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$155K Buy
52,100
+28,900
+125% +$1.69M 0.01% 444
2025
Q2 		$90.9K Sell
23,200
-4,900
-17% -$333K 0.01% 447
2025
Q1 		$42.7K Buy
28,100
+15,700
+127% +$1.3M ﹤0.01% 488
2024
Q4 		$11.8K Buy
+12,400
New +$1.34M ﹤0.01% 610
2024
Q1 		– Sell
-13,600
Closed -$50.7K – 956
2023
Q4 		$50.7K Buy
+13,600
New +$1.34M 0.01% 451
2022
Q1 		– Sell
-131,600
Closed -$160K – 2617
2021
Q4 		$160K Buy
+131,600
New +$7.13M ﹤0.01% 1088
2019
Q3 		– Sell
-138,400
Closed -$26K – 1338
2019
Q2 		$26K Buy
+138,400
New +$3.42M ﹤0.01% 845

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

HAP Trading's NVO Position: Q3 2025 in Review

HAP Trading sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 44,060 shares — an estimated $2.58M sold.

HAP Trading first reported a position in NVO in Q4 2021 and held it in 3 quarters. The position peaked at $3.04M in Q2 2025. 1,396 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • HAP Trading reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • HAP Trading sold 44,060 Novo Nordisk shares in Q3 2025, an estimated $2.58M.
  • HAP Trading first reported a position in Novo Nordisk in Q4 2021 and held it in 3 quarters.
  • HAP Trading's Novo Nordisk position peaked at $3.04M in Q2 2025.
  • 1,396 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on HAP Trading's 13F filing for Q3 2025, filed 12 Nov 2025.